Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
08/2012
08/16/2012US20120208998 Polycyclic carbamoylpyridone derivative having hiv integrase inhibitory activity
08/16/2012US20120208997 Novel compound having heterocyclic ring
08/16/2012US20120208841 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator
08/16/2012US20120208830 Anhydrous Crystalline Forms of N-[1-(2-ethoxyethyl)-5-(N-ethyl-N-methylamino)-7-(4-methylpyridin-2-yl-amino)-1H-pyrazolo[4,3-d]pyrimidine-3-carbonyl]methanesulfonamide
08/16/2012US20120208820 Diazabicyclic central nervous system active agents
08/16/2012US20120208812 DISUBSTITUTED OCTAHYDROPYRROLO[3,4-c]PYRROLES AS OREXIN RECEPTOR MODULATORS
08/16/2012US20120208810 Novel 1,2,3,4-tetrahydro-pyrimido(1,2-a)pyrimidin-6-one derivatives, preparation thereof, and pharmaceutical use thereof
08/16/2012US20120208808 Pyrazolopyrimidine derivatives
08/16/2012US20120208805 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
08/16/2012US20120208799 Compounds
08/16/2012US20120208796 Heterocyclic derivatives
08/16/2012US20120208172 Methods of Increasing Liver Proliferation
08/16/2012US20120207769 Inhibitors of IAP
08/16/2012US20120205636 Compound for organic photoelectric device and organic photoelectric device including the same
08/16/2012CA2826757A1 Substituted [(5h-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dimethylpropanoic acid compounds as dual activity h1 inverse agonists/5-ht2a antagonists
08/16/2012CA2825028A1 Heterocyclic compounds as pi3 kinase inhibitors
08/15/2012EP2486043A1 [18 f]- labelled analogues of flumazenil as in vivo imaging agents
08/15/2012EP2486042A1 Bicyclic heterocycles and their use as ccr2 receptor antagonists
08/15/2012EP2486041A1 Hydroxyl, keto, and glucuronide derivatives of 3-(4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl)-3-cyclopentylpropanenitrile
08/15/2012EP2486040A1 Automated radiosynthesis
08/15/2012EP2486036A2 Materials for organic electroluminescent devices
08/15/2012EP2486031A2 Phenylpyri(mi)dinylpyrazoles and their use as fungicides
08/15/2012EP2485731A1 Heterocyclic compounds useful as pdk1 inhibitors
08/15/2012EP2485589A1 Heteroaryl btk inhibitors
08/15/2012EP2297159B1 Substituted quinazolines
08/15/2012EP2276756B9 Hydroxymethyl pyrrolidines as beta 3 adrenergic receptor agonists
08/15/2012EP2188283B1 Annelated pyridazines for the treatment of tumors driven by inappropriate hedgehog signalling
08/15/2012EP1656370B1 Biaryl heterocyclic compounds and methods of making and using the same
08/15/2012CN1351498B Pyrrolotriazines inhibitors of kinases
08/15/2012CN102639541A Method for preparing silica particles containing a phthalocyanine derivative, said particles, and uses thereof
08/15/2012CN102639532A Fused triazole amines as P2X7 modulators
08/15/2012CN102633842A Preparation method and application of ionic liquid desulfurizer with bimetal reactivity center
08/15/2012CN102633804A Method for preparing 7-Azabicyclo[2.2.1]heptane
08/15/2012CN102633803A Synthetic method of 5,7-dichloro pyrazole [1,5-a] pyrimidine
08/15/2012CN102633802A Intermediate for synthesizing 2-chloro-7H-pyrrolo (2, 3-d) pyrimidine and preparation method thereof
08/15/2012CN102633732A Phthalazine-like derivative and application thereof
08/15/2012CN102633716A Bicyclic inhibitors of mek and methods of use thereof
08/15/2012CN102633582A Diaryl compound and preparation method thereof
08/15/2012CN102633314A Low-concentration formaldehyde wastewater resource recycling process
08/15/2012CN101847479B Microwave composite material and preparation method thereof
08/15/2012CN101495117B Aqueous liquid preparation containing amide compound
08/15/2012CN101489559B Purine and deazapurine derivatives as pharmaceutical compounds
08/15/2012CN101432284B Dihydropyrazolopyrimidinone derivative
08/14/2012US8242263 Composition for photon-energy up-conversion
08/14/2012US8242262 Process for preparing chlorides of phthalocyanine derivatives comprising at least a quaternary ammonium group
08/14/2012US8242125 Heterobicyclic carboxamides as inhibitors for kinases
08/14/2012US8242120 Carbocyclic compounds and methods for treating emerging disease, including influenza and Venezuela equine encephalitis virus
08/14/2012US8242118 Arylsulfonamide derivatives for use as CCR3 antagonists in the treatment of inflammatory and immunological disorders
08/14/2012CA2527496C 4-substituted derivatives of pyrazolo [3,4-d] pyrimidine and pyrrolo [2,3-d] pyrimidine and uses thereof
08/09/2012WO2012106522A2 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
08/09/2012WO2012106343A2 Hdac inhibitors and therapeutic methods using the same
08/09/2012WO2012105629A1 Nitrogenated heterocyclic derivative, electron-transporting material for organic electroluminescent elements, and organic electroluminescent element using same
08/09/2012WO2012105594A1 Ring-fused heterocyclic derivative
08/09/2012WO2012105483A1 Method for producing metal complex of compound that has porphyrin skeleton
08/09/2012WO2012104776A1 Novel heterocyclic derivatives
08/09/2012WO2012104388A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012WO2012104293A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/09/2012WO2012046030A3 Phosphodiesterase inhibitors
08/09/2012US20120202992 Pyrazolo[1,5-a] pyrimidine compounds as cb1 receptor antagonist
08/09/2012US20120202834 Glucagon receptor modulators
08/09/2012US20120202829 6-Cycloalkyl-pyrazolopyrimidinones for the Treatment of CNS Disorders
08/09/2012US20120202809 Novel n-pyrimidin-4-yl-3-amino-pyrrolo[3,4-c]pyrazole derivatives as pkc kinase inhibitors
08/09/2012US20120202805 PI3K (delta) SELECTIVE INHIBITORS
08/09/2012US20120202800 Dual small molecule inhibitors of cancer and angiogenesis
08/09/2012US20120202799 Condensed Azepine Derivatives As Bromodomain Inhibitors
08/09/2012US20120202797 SUBSTITUTED [(5H-PYRROLO[2,1-c][1,4]BENZODIAZEPIN-11-YL)PIPERAZIN-1-YL]-2,2-DIMETHYLPROPANOIC ACID COMPOUNDS AS DUAL ACTIVITY H1 INVERSE AGONISTS/5-HT2A ANTAGONISTS
08/09/2012US20120202792 Antimicrobial Compounds and Methods of Making and Using the Same
08/09/2012US20120202785 Heterocyclic compounds and methods of use
08/09/2012US20120202783 Fused heterocyclic compounds as orexin receptor modulators
08/09/2012US20120202782 Compounds and compositions as itpkb inhibitors
08/09/2012US20120202690 Herbicidal compounds
08/09/2012US20120202287 Stem Cell Culture Methods
08/09/2012US20120199256 Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects
08/09/2012CA2826295A1 Bicyclic and tricyclic pyrimidine tyrosine kinase inhibitors with antitubulin activity and methods of treating a patient
08/09/2012CA2825605A1 Novel heterocyclic derivatives
08/09/2012CA2825599A1 Hdac inhibitors and therapeutic methods using the same
08/09/2012CA2825279A1 New azaindolylphenyl sulfonamides as serine/threonine kinase inhibitors
08/09/2012CA2824929A1 (1,2,4)triazolo[4,3-a]quinoxaline derivatives as inhibitors of phosphodiesterases
08/08/2012EP2484682A2 Synthesis of boron dipyrromethenes with laser properties
08/08/2012EP2484679A2 N3-heteroaryl substituted triazoles and n5-heteroaryl substitued triazoles useful as axl inhibitors
08/08/2012EP2484667A1 Optically active quaternary ammonium salt having axial asymmetry and process for producing alpha-amino acid and derivative thereof with the same
08/08/2012EP2483368A1 Electroluminescent materials comprising fluorene derivatives
08/08/2012EP2483274A2 Antimalarial agents that are inhibitors of dihydroorotate dehydrogenase
08/08/2012EP2483273A1 Novel macrocyclic inhibitors of hepatitis c virus replication
08/08/2012EP2483272A2 Pi3k (delta) selective inhibitors
08/08/2012EP2483255A1 Oxazine derivatives and their use in the treatment of neurological disorders
08/08/2012EP2483222A2 Suspensions of hexanitrohexaazaisowurtzitane crystals, production of said suspensions and production of pyrotechnic objects
08/08/2012EP2114158B1 3-substituted-[1,2,3]benzotriazinone compounds for enhancing glutamatergic synaptic responses
08/08/2012EP2016067B1 Insecticidal compounds
08/08/2012EP1831226B1 Chiral tetracyclic compounds inducing interferon biosynthesis
08/08/2012EP1824855B1 Novel pyrrolo [3, 2-d]pyrimidin-4-one derivatives and their use in therapy
08/08/2012CN102627657A Synthetic method of 3-(4-methoxy-benzyl)-1H-pyrimidine-2,4-dione derivative
08/08/2012CN102627650A Chiral spiro(pyrrolidine-3, 2'-oxindole)compound and synthesis method thereof
08/08/2012CN102627649A Small molecule inhibitors of MDM2 and uses thereof
08/08/2012CN102627648A Preparation method of sitagliptin
08/08/2012CN102627647A Synthetic method of 4-chloro-5-methylpyrrolo[2,1-f][1,2,4]triazine
08/08/2012CN102627646A Preparation method of 3-iodo-5-bromo-4, 7-diazaindole
08/08/2012CN102627645A Novel pyrazolopyrimidines as cyclin dependent kinase inhibitors
08/08/2012CN102627632A Amino quinazoline derivative and preparation method as well as application thereof
08/08/2012CN102626657A Preparation method of catalyst for catalyzing rich gas catalytic oxidation desulfurization
1 ... 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 ... 573